{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:47:17Z","timestamp":1793314037450,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.vaccine.2011.05.068","type":"journal-article","created":{"date-parts":[[2011,6,18]],"date-time":"2011-06-18T12:49:12Z","timestamp":1308401352000},"page":"5407-5413","source":"Crossref","is-referenced-by-count":30,"title":["SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine"],"prefix":"10.1016","volume":"29","author":[{"given":"Holly D.","family":"Clifford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew-Kim","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie T.","family":"Yerkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Le Sou\u00ebf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.05.068_bib0005","first-page":"418","article-title":"Progress in global measles control and mortality reduction, 2000\u20132006","volume":"82","author":"Centers for Disease Control Prevention (CDC)","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2011.05.068_bib0010","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0264-410X(99)00309-6","article-title":"Measles elimination: progress and challenges","volume":"17","author":"Cutts","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.068_bib0015","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jama.1983.03340110023025","article-title":"Antibody response following measles\u2013mumps\u2013rubella vaccine under conditions of customary use","volume":"250","author":"Brunell","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.05.068_bib0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/376260a0","article-title":"A novel receptor involved in T-cell activation","volume":"376","author":"Cocks","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2011.05.068_bib0025","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.185.6.993","article-title":"Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes","volume":"185","author":"Punnonen","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2011.05.068_bib0030","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1099\/0022-1317-83-6-1431","article-title":"Analysis of receptor (CD46 CD150) usage by measles virus","volume":"83","author":"Erlenhofer","year":"2002","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.068_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/79815","article-title":"DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking","volume":"1","author":"Geijtenbeek","year":"2000","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.05.068_bib0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","article-title":"DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.068_bib0045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20021840","article-title":"DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells","volume":"197","author":"Tassaneetrithep","year":"2003","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.068_bib0050","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1128\/JVI.80.7.3477-3486.2006","article-title":"Measles virus targets DC-SIGN to enhance dendritic cell infection","volume":"80","author":"de Witte","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.05.068_bib0055","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/sj.gene.6364051","article-title":"Genetic regulation of immune responses to vaccines in early life","volume":"5","author":"Newport","year":"2004","journal-title":"Genes Immun"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2011.05.068_bib0060","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/S0264-410X(00)00468-0","article-title":"Twin studies of immunogenicity\u2014determining the genetic contribution to vaccine failure","volume":"19","author":"Tan","year":"2001","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2011.05.068_bib0065","doi-asserted-by":"crossref","first-page":"14053","DOI":"10.1128\/JVI.78.24.14053-14056.2004","article-title":"Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection","volume":"78","author":"Martin","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.068_bib0070","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1371\/journal.pmed.0030020","article-title":"Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis","volume":"3","author":"Barreiro","year":"2006","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.vaccine.2011.05.068_bib0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ng1550","article-title":"A variant in the CD209 promoter is associated with severity of dengue disease","volume":"37","author":"Sakuntabhai","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2011.05.068_bib0080","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaci.2007.04.036","article-title":"Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors","volume":"120","author":"Dhiman","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2011.05.068_bib0085","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.vaccine.2006.11.022","article-title":"Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants","volume":"25","author":"Yerkovich","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.068_bib0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/320996","article-title":"Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic Th1 function","volume":"184","author":"Rowe","year":"2001","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.068_bib0095","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jaci.2003.12.585","article-title":"High IFN-gamma production by CD8+ T cells and early sensitization among infants at high risk of atopy","volume":"113","author":"Rowe","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.068_bib0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jir.1992.12.67","article-title":"A whole blood immunoassay for the interferon-inducible human Mx protein","volume":"12","author":"Towbin","year":"1992","journal-title":"J Interferon Res"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.068_bib0105","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/infdis\/169.4.807","article-title":"MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon","volume":"169","author":"Roers","year":"1994","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.068_bib0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/abio.2001.5369","article-title":"Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR","volume":"299","author":"Hamalainen","year":"2001","journal-title":"Anal Biochem"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2011.05.068_bib0115","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1034\/j.1600-0463.2003.11107803.x","article-title":"Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity","volume":"111","author":"Geijtenbeek","year":"2003","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2011.05.068_bib0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0264-410X(96)00124-7","article-title":"Kinetics of immunologic responses after primary MMR vaccination","volume":"15","author":"Pabst","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.068_bib0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-1119(03)00674-7","article-title":"Isolation and characterization of the human DC-SIGN and DC-SIGNR promoters","volume":"313","author":"Liu","year":"2003","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.068_bib0130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/intimm\/13.7.897","article-title":"Mechanisms of cytokine synergy essential for vaccine protection against viral challenge","volume":"13","author":"Ahlers","year":"2001","journal-title":"Int Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.068_bib0135","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.068_bib0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/510596","article-title":"Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes","volume":"195","author":"Dhiman","year":"2007","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.05.068_bib0145","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1086\/500144","article-title":"Human leukocyte antigen haplotypes in the genetic control of immune response to measles\u2013mumps\u2013rubella vaccine","volume":"193","author":"Ovsyannikova","year":"2006","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2011.05.068_bib0150","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.vaccine.2008.01.017","article-title":"Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results","volume":"26","author":"Dhiman","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.068_bib0155","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What's wrong with Bonferroni adjustments","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11008152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11008152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T01:55:29Z","timestamp":1543715729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11008152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":31,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0264410X11008152"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}